Kanada - Englisch - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 4mg; 500mg - rosiglitazone (rosiglitazone maleate) 4mg; metformin hydrochloride 500mg - biguanides

Kanada - Englisch - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 2mg; 1000mg - rosiglitazone (rosiglitazone maleate) 2mg; metformin hydrochloride 1000mg - biguanides

Kanada - Englisch - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 4mg; 1000mg - rosiglitazone (rosiglitazone maleate) 4mg; metformin hydrochloride 1000mg - biguanides

Israel - Englisch - Ministry of Health

novo nordisk ltd., israel - repaglinide - tablets - repaglinide 0.5 mg - repaglinide - repaglinide - repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. repaglinide is also indicated in combination with metformin in adults with type 2diabetes mellitus who are not satisfactorily controlled on metformin alone.treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.

Israel - Englisch - Ministry of Health

novo nordisk ltd., israel - repaglinide - tablets - repaglinide 1 mg - repaglinide - repaglinide - repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. repaglinide is also indicated in combination with metformin in adults with type 2 diabetes mellitus who are not satisfactorily controlled on metformin alone.treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.

Israel - Englisch - Ministry of Health

novo nordisk ltd., israel - repaglinide - tablets - repaglinide 2 mg - repaglinide - repaglinide - repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. repaglinide is also indicated in combination with metformin in adults with type 2 diabetes mellitus who are not satisfactorily controlled on metformin alone.treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - metformin hydrochloride -

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - metformin hydrochloride -

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

actavis new zealand limited - metformin hydrochloride 1000mg;  ;   - coated tablet - 1000 mg - active: metformin hydrochloride 1000mg     excipient: magnesium stearate opadry clear oy-29020 povidone water - -treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. -metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents. - adjuvant therapy in insulin dependent diabetes especially if overweight.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

actavis new zealand limited - metformin hydrochloride 500mg;  ;   - coated tablet - 500 mg - active: metformin hydrochloride 500mg     excipient: magnesium stearate opadry clear oy-29020 povidone water - -treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. -metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents. - adjuvant therapy in insulin dependent diabetes especially if overweight.